Streptococcus suis serotype 2 is an important swine pathogen mainly associated with arthritis, endocarditis, meningitis, pneumonia, and septicemia (49, 66) . It is also a major zoonotic agent for humans in contact with colonized, otherwise healthy pigs or their by-products, causing life-threatening infections. Recently, we reported an unprecedented epidemic in China in 2005, which resulted in 204 human cases (69) . In particular, 18.6% of these human patients died from streptococcal toxic shock syndrome (STSS), implying that this important pathogenic species has evolved some new mechanisms to enhance its pathogenicity. To further pursue this issue, we have decoded the complete genomic sequences of two highly virulent S. suis serotype 2 isolates and identified a new pathogenicity island, referred to as 89K, which is prevalent in STSS-causing S. suis serotype 2 isolates (11) . Very recently, we provided genetic evidence that 89K functions as a pathogenicity island and even claimed high virulence of Chinese isolates (46) . Efforts are still being made in our joint research to achieve a comprehensive understanding of the pathogenesis of S. suis serotype 2 infection.
Two-component signal transduction systems (TCSs) play important roles in bacterial gene expression (including that of many virulence-related genes) in response to a variety of environmental stimuli (19) . In general, a TCS consists of a sensor kinase and an effector, or response regulator, which is generally a DNA-binding protein that modulates the expression of certain target genes. In S. suis serotype 2, at least 15 TCSs have been identified (11) . Among them, only the orphan response regulator RevS (14) and the SalK-SalR (46) system have been reported and shown to positively control S. suis serotype 2 virulence. It is known that bacterial virulence is tightly regulated by both positive and negative feedback mechanisms. Therefore, environmental regulation of virulence gene expression in S. suis serotype 2 via TCSs deserves to be further addressed.
The newly sequenced genome of S. suis 05ZYH33, a highly pathogenic strain isolated from a Chinese STSS patient, enabled the identification of an orthologue of the CovR (for control of virulence) regulator (also known as CsrR, for capsule synthesis regulator) known to be involved in the virulence of Streptococcus pyogenes (group A streptococcus [GAS] ) and Streptococcus agalactiae (group B streptococcus [GBS] ) (22, 42) . Unlike the other streptococcal CovS-CovR systems, covR is not located in the genome of S. suis 05ZYH33 next to a cognate histidine kinase; therefore, CovR was considered to be an orphan response regulator. In GAS, the global regulatory two-component system CovS-CovR controls the expression of nearly 15% of all chromosomal genes, including many that encode surface and secreted proteins mediating pathogen-host interactions, such as hyaluronic acid capsule, cysteine protease (pyrogenic exotoxin), streptokinase, streptolysin S, and streptodornase (22) . Moreover, CovR was shown to play a central role in gene regulatory networks by influencing the expression of genes encoding transcriptional regulators, including other TCSs. Additionally, consistent with increased virulence gene transcription, a covR-defective mutant exhibited enhanced virulence in the mouse and increased resistance to human polymorphonuclear leukocyte (PMN)-mediated killing (17, 18, 27, 45) . Similarly, in the case of GBS, a close relative of GAS, CovS-CovR also has a pleiotropic effect, influencing the transcription of about 7% of GBS genes (42) . Interestingly, a ⌬covSR mutant showed remarkable phenotypic changes, such as increased hemolytic activity and hyperadhesion to epithelial cells. In contrast to the pathogenic role of CovS-CovR in GAS, a mutant in the covSR locus in GBS was attenuated in virulence in an intraperitoneal-injection model (31, 42) . As in S. suis 05ZYH33, CovR in S. mutans is also an orphan response regulator and has been shown to be essential for biofilm development and cariogenesis (28) .
Here, we show that the orphan response regulator CovR plays a crucial role in negatively controlling the virulence of S. suis serotype 2. A genome scale overview of the CovR regulatory network indicates that CovR is a global virulence regulator in S. suis serotype 2.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . S. suis serotype 2 strains were grown in Todd-Hewitt broth (THB) (Difco Laboratories, Detroit, MI) and plated on THB agar (Biotrading) containing 6% (vol/vol) sheep blood. E. coli strains were grown in Luria broth and plated on Luria broth containing 1.5% (wt/vol) agar. If required, antibiotics were added in the following concentrations: 50 g/ml of spectinomycin (Sigma, St. Louis, MO) for the S. suis serotype 2 mutant strain, 5 g/ml of chloramphenicol (Sigma, St. Louis, MO) and 50 g/ml spectinomycin for the complemented strain, and 100 g/ml of spectinomycin, 10 g/ml of chloramphenicol, and 100 g/ml of ampicillin (Boehringer, Mannheim, Germany) for Escherichia coli.
Construction of a covR knockout mutant. To construct the mutant strain ⌬covR, the covR gene was insertionally inactivated in S. suis serotype 2 strain 05ZYH33 with a spectinomycin resistance cassette. A 3.4-kb DNA fragment containing the covR gene and its flanking regions was amplified from 05ZYH33 genomic DNA with primers LA and RA ( Table 2 lists the sequences of the primers used) and then cloned into the pMD18-T cloning vector (TaKaRa, Japan) to create pMD-covR. Subsequently, a 1.1-kb spectinomycin resistance cassette (amplified from the plasmid pSET2) was inserted into a unique XhoI site within the covR coding sequence in pMD-covR to generate the covR knockout vector pMD::covR. Since the spc gene does not carry a terminator, insertion of spc is expected to be nonpolar. Plasmid pMD::covR was used to electrotransform S. suis 05ZYH33 as described previously (64) . Spectinomycin-resistant transformants were selected on THB supplemented with 0.5% yeast extract containing the appropriate antibiotic, and PCR analysis with flanking primers lying outside the homologous regions and reverse transcription (RT)-PCR detection were carried out to confirm that covR inactivation had occurred by double-crossover recombination.
Complementation of the covR inactivation. For complementation assays, a DNA fragment containing the entire covR gene and its upstream promoter was amplified using primers C-F and C-R, which introduced EcoRI and PstI sites, respectively. After digestion with the appropriate restriction enzymes, the resulting fragment was cloned into the E. coli-S. suis shuttle vector pSET1 (68) at the EcoRI/PstI sites to generate the covR-complementing plasmid pSET1::covR. This vector was electrotransformed directly into the ⌬covR mutant to obtain the complemented strain C⌬covR using our previously reported method (46) .
Transmission electron microscopy (TEM). The samples from agar-grown bacteria (05ZYH33 and the ⌬covR strain) were prepared by conventional methods. Briefly, bacterial cells were fixed in 5% glutaraldehyde for 2 h, postfixed with 1% osmium tetroxide for 1 h, dehydrated in ethanol, and embedded in Epon-812 epoxy resin. Thin sections were poststained with uranyl acetate and lead citrate and examined with a JEM-1010 transmission electron microscope (Jeol Ltd., Tokyo, Japan) at an accelerating voltage of 100 kV. Capsule thickness measurements were made on 20 to 25 randomly chosen cells of each strain.
Titration of hemolytic activity. Hemolysin units in the culture supernatant were determined as described by Jacobs et al. (30) , with slight modifications. Briefly, 2% sheep red blood cells in phosphate-buffered saline (PBS) were prepared, and 150 l of the red blood cells was added to serial twofold dilutions of culture supernatant of 05ZYH33 and the ⌬covR strain. The microplate was incubated at 37°C for 2 h and then centrifuged at 600 ϫ g for 10 min; 150 l of supernatant was transferred to a new plate and read at 540 nm with a micro-ELISA reader (Bio-Tek, Synergy HT). Hemolysin units were determined as the reciprocal of the highest dilution of hemolysin that induced at least 50% lysis of erythrocytes.
Adherence assays. For cell adhesion assays, bacteria were centrifuged, washed three times with PBS, and resuspended at 10 6 CFU/ml in RPMI 1640 medium without antibiotics as previously described (74, 75) . Human umbilical vein endothelial cells (HUVEC) were isolated by collagenase digestion of umbilical veins from undamaged sections of fresh cords. The human laryngeal epithelial cell line Hep-2 (CCTCC GDC004) and HUVEC were cultured at 37°C and 5% CO 2 in RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (FBS) (Gibco-BRL). Cell monolayers (HUVEC and Hep-2) were infected at a multiplicity of infection of 10 bacteria per cell. Before the adhesion experiment, the broth cultures were vigorously vortexed with a vortex mixer to disperse any aggregates and to generate short bacterial chains containing a maximum of six cocci, as visualized by phase-contrast microscopy. The plates were centrifuged at 800 ϫ g for 10 min and incubated in RPMI 1640 medium without FBS for 1 h at 37°C with 5% CO 2 . The monolayers were washed five times with PBS and incubated with 20 l of 0.05% trypsin/0.03% EDTA for 10 min at 37°C. After the addition of 80 l of ice-cold deionized water, the cells were detached and disrupted by scraping the bottoms of the wells. Serial dilutions of the cell lysates were plated onto THB agar to enumerate viable bacteria. The percent adherence was calculated as follows: (CFU on plate/CFU in original inoculum) ϫ 100%. Assays were performed in duplicate and were repeated at least three times.
Cell-killing experiments. PMNs (also called neutrophils) and monocytes (MONOs) were isolated from heparinized venous blood of healthy human volunteers or healthy piglets using the method of dextran sedimentation as described by Baltimore et al. (1) . Bacteria were opsonized in 10% normal human or pig serum and incubated with human or pig PMNs at a ratio of 10:1 (bacteriacell) for 1 h. For each strain, controls included samples containing PMNs and heat-inactivated sera and samples lacking PMNs but containing human or pig sera. Cells were lysed with 0.1% saponin (20 min on ice), and serial dilutions of the lysates were plated on THB agar. Colonies were counted, and the percentage of S. suis serotype 2 bacteria that survived was determined as follows: (CFU PMNϩ /CFU PMNϪ ) ϫ 100% (36) . The MONO-mediated killing assay was performed in a manner similar to the PMN-killing assay. Each assay was performed in triplicate.
Experimental infections of piglets. For virulence studies, 3-week-old specificpathogen-free (SPF) piglets (six pigs/group) were challenged intravenously with the ⌬covR strain and the complemented strain C⌬covR at a dose of 10 8 CFU/ piglet. The parental wild-type strain, 05ZYH33, and an avirulent strain, 05HAS68, served as positive and negative controls, respectively. The infected piglets were monitored for clinical signs, and their survival times were recorded. All animal experiments were performed in a biosafety level 3 facility and approved by the local ethical committee.
Competitive-infection assay. To precisely distinguish virulence in the wild-type strain, 05ZYH33, and the mutant ⌬covR strain, 50% lethal doses of both strains would have to be determined, and a large number of piglets would be required. For ethical reasons, this is not acceptable. To circumvent this problem, a competitive-infection assay was used to compare the capabilities of the ⌬covR mutant and its parental strain to colonize different tissues of piglets. A group of six piglets were inoculated intravenously with a mixture of wild-type and mutant bacteria at a ratio of 1:1 (5 ϫ 10 7 CFU). During the experiment, the piglets that developed typical S. suis serotype 2 infection symptoms were sacrificed for bacterial-colonization analysis by using previously reported methods (15) .
Pathological examination by light and electron microscopy. To examine the differences in pathological changes produced by the wild-type strain, 05ZYH33, and the ⌬covR mutant, kidney and heart tissues from the autopsy specimens of piglets were selected to prepare sections for light microscopy and TEM observation by using methods described previously (69) .
Microarray-based comparative analysis of the ⌬covR strain. DNA microarray design and synthesis, as well as cDNA labeling and hybridization, were performed as previously described (46) . Statistically significant differences were defined as those with a t test P value of less than 0.05 and a ratio of change threshold of at least 2 standard deviations compared to the median ratio for each strain.
Real-time PCR evaluation. Microarray data were subjected to further confirmation in nine chosen genes with real-time PCR assays as described previously 
RESULTS
Bioinformatics-based identification of a covR gene in S. suis 05ZYH33. In the genome of S. suis 05ZYH33, the peptide encoded by 05SSU1732 exhibits 46% and 59% amino acid sequence identity with the CovR response regulators of S. pyogenes and Streptococcus sanguinis SK36, respectively, belonging to the widespread OmpR family, and hence, 05SSU1732 was renamed covR. However, in the vicinity of covR, no cognate histidine kinase was identified (see Table S1 in the supplemental material). Therefore CovR was considered to be an orphan response regulator in S. suis 05ZYH33. The nucleotide sequence of the covR gene of 05ZYH33 is almost identical to those of S. suis serotype 2 strains 89/1591 and P1/7. PCR analysis amplifying the covR locus revealed that covR is present in all 35 known serotypes of S. suis (types 1 to 34 and type 1/2), with the one exception of serotype 20 (data not shown).
Construction and characterization of a covR-defective mutant. To investigate the role of CovR in S. suis 05ZYH33, an isogenic covR knockout mutant was constructed. The covR coding sequence was cloned and disrupted at amino acid position 152 by inserting a spectinomycin resistance gene before its transfer into the 05ZYH33 chromosome by allelic exchange (Fig. 1A) . The double-crossover event was confirmed by PCR (Fig. 1B) and DNA sequencing (data not shown), as well as by RT-PCR analysis (Fig. 1C) .
Prior to evaluating the effect of covR inactivation on the virulence of S. suis 05ZYH33 in vivo, we first examined the growth characteristics of the ⌬covR mutant in vitro. A slight difference in growth of the wild-type and mutant strains was reproducibly observed. The ⌬covR mutant grew at a lower rate than the parent strain in THB both with and without 10% FBS (Fig. 2) . More interestingly, the mean chain length of the ⌬covR strain was found to be much longer than that of the wild-type strain under the same growth conditions (Fig. 3A) . TEM revealed that the capsule of the ⌬covR strain is thicker than that of its parental strain, 05ZYH33 (Fig. 3B) . The thickness of the capsular material for 05ZYH33 and the ⌬covR strain ranged between 37 and 74 nm and between 55 and 112 nm, respectively.
When inoculated on sheep blood agar plates, the ⌬covR strain tended to induce bigger hemolytic zones than the wildtype strain (Fig. 4A ). This observation was confirmed by measuring hemolytic activities in a photometric assay. The hemolytic titer of the ⌬covR mutant (2 8 unit) was approximately twofold higher than that of 05ZYH33 (2 7 unit) (Fig. 4B ), suggesting that covR inactivation would enhance the hemolytic activity of S. suis serotype 2.
Hyperadhesion of the ⌬covR strain to epithelial and endothelial cells. Adherence of pathogenic bacteria to the mucosal surface is considered to be an essential step in the infectious process. To determine whether the lack of CovR affected the cellular adhesion of S. suis serotype 2, the adherence efficiencies of the wild-type strain and the ⌬covR mutant to human epithelial (Hep-2) or endothelial (HUVEC) cells were compared. As shown in Fig. 5 , the ⌬covR mutant showed significantly more adhesion to both Hep-2 cells and HUVEC (P Ͻ 0.01) than the wild-type strain, indicating the role of CovR as an important mediator in the cellular-adhesion process.
Increased resistance of the ⌬covR strain to phagocytosis and killing by neutrophils and MONOs. The ability of PMNs and MONOs to kill a diverse array of bacterial pathogens is essential for innate host defense (3). Therefore, we investigated the ingestion and killing of the wild-type and mutant strains by human and porcine PMNs and MONOs. In PMN-mediated killing assays, a higher percent survival of ⌬covR bacteria (64% Ϯ 10%) than of 05ZYH33 (42% Ϯ 11%) (P Ͻ 0.05) was observed after a 1-hour incubation (Fig. 6) , and significantly more mutant strain bacteria (72% Ϯ 12%) than wild-type bacteria (45% Ϯ 10%) (P Ͻ 0.05) were associated with human MONOs. Similar phenomena were observed in porcine PMN and MONO-mediated killing assays (data not shown). These results indicate that covR disruption leads to increased resistance of the pathogen to phagocytosis and killing by PMNs and MONOs or production of bacterial factors that alter normal PMN and MONO function during bacterium-cell interactions. For example, in GAS, the covRS mutant had enhanced activity of the protease SpyCEP (S. pyogenes cell envelope protease) to cleave granulocyte chemotactic protein 2 (GCP-2) and growth-related oncogene ␣ (GRO␣), two potent chemokines involved in the activation of neutrophils, thus impairing the host innate immune response (67) .
Enhanced virulence of ⌬covR in a piglet infection model. An experimental infection model in SPF piglets was designed to assess the role of CovR in virulence. As an initial comparison of virulence, groups of six piglets were challenged intravenously with either the wild-type strain, 05ZYH33; the ⌬covR mutant; the complemented strain, C⌬covR; or an avirulent strain, 05HAS68 (Fig. 7) . We noticed that all six piglets infected with 05ZYH33 developed most of the typical disease symptoms, including high fever, limping, swollen joints, shiv- ering, central nervous system failure, and respiratory failure within 24 h. Five of them died on day 2 postinfection and the last one on day 3. The bacteria could be reisolated from tissues of the piglets, including the heart, lung, and liver. In contrast, all piglets inoculated with the avirulent strain 05HAS68 as a negative control did not show any clinical symptoms, and no deaths occurred over a 14-day period of observation. However, piglets challenged with the ⌬covR mutant died within 9 to 14 h without showing any obvious signs of disease, such as high fever and central nervous system failure. It seemed that the ⌬covR mutant could cause sudden death. All of the piglets infected with the complemented strain C⌬covR died, with a median survival time of 2 days, similar to that observed in the wild-type group. In response to the sudden death caused by the ⌬covR strain, pathological examination was carried out by light and electron microscopy. For the wild-type-infected group, the glomeruli in the cortical area were enlarged and the cells, especially capillary endothelial cells, proliferated obviously and became swollen, with resulting narrowed capillary lumens and vascular collapse (Fig. 8A ). Degeneration and exfoliation of the renal tubular epithelium were observed, and the microvilli of the renal tubular epithelium were decreased or lost ( Fig. 8A and E). Chondriosomes were swollen with the disruption of mitochondrial cristae (Fig. 8E) . In heart tissue, the cardiac muscle fibers were arranged regularly, although accompanied by sarcoplasmic lysis, decreased muscle bundles, and scarce transverse striation (Fig. 8C ). Swollen mitochondria with disrupted cristae and dilated endoplasm were also observed (Fig. 8G) . Apoptotic cells were occasionally seen. For the mutant-infected group, pathological alterations similar to those in the wild-type-infected group were observed, but to a more serious degree. More importantly, disseminated intravascular coagulation in kidney tissue and focal hemorrhages in the stratum of the heart could be exclusively identified in the mutant-infected group (Fig. 8B and D) .
In the second series of experiments, a competitive-infection assay was adopted to further compare the virulence of the wild-type strain, 05ZYH33, and that of the ⌬covR mutant by challenging a group of six piglets with a 1:1 mixture of wildtype and mutant bacteria. From various tissue samples of infected piglets, the percentage of each strain within the population was calculated. As shown in Fig. 9 , the percentages varied greatly in different tissue samples. In most of the organs examined, including heart, liver, kidney, and brain, the numbers of mutant bacteria reisolated were considerably higher than those of the wild-type strain (P Ͻ 0.05). In contrast, the ⌬covR mutant colonized the lung tissue to a lesser degree than the wild-type strain (P Ͻ 0.05). Additionally, similar numbers of wild-type and mutant bacteria were reisolated from lymph nodes (P Ͼ 0.05), suggesting that both strains colonized this organ with the same efficiency. Taken together, these results indicated that inactivation of covR enhances the capability of S. suis 05ZYH33 to disseminate and cause a systemic infection.
DNA microarray identification of CovR-regulated genes. To identify CovR-regulated genes and also putative virulenceassociated transcriptional alterations in the ⌬covR mutant, a DNA microarray-based comparative-transcriptomics approach was applied. As expected, the expression levels of flanking genes of covR were found to be unaltered in the ⌬covR mutant, thus confirming that insertion of the spectinomycin cassette into covR does not have a polar effect on downstream genes. In total, the inactivation of covR led to 195 differentially expressed genes spread throughout the genome (8.9%) (see Ta- ble S2 in the supplemental material), with a twofold cutoff, indicating a global regulatory role of this orphan response regulator. Of these, 193 genes were CovR repressed and 2 genes were positively regulated by CovR. These regulated FIG. 9 . Differential colonization abilities of the wild-type and ⌬covR mutant strains in susceptible tissues of piglets. The ⌬covR mutant was mixed with the wild type at a ratio of 1:1 and inoculated intravenously into six SPF piglets. When typical S. suis serotype 2 infection symptoms developed, the piglets were sacrificed, the bacteria recovered from various tissues were enumerated, and the percentage of each strain within the population was calculated. The data are expressed as the means and standard deviations of three independent experiments. *, P Ͻ 0.05. Validation of the microarray results by real-time PCR analysis. In order to independently confirm the microarray data, the relative transcript levels of nine selected genes were measured by quantitative real-time PCR analysis. These nine genes were chosen because the majority of them were identified as encoding factors influencing bacterium-host interactions. Of these, seven genes (05SSU0330 [lbp], 05SSU1668 [hly], 05SSU1074 [srtA], 05SSU0566 [cps2C], 05SSU0581, 05SSU1285, and 05SSU2011) were upregulated and the other two (05SSU1367 and 05SSU1660) were downregulated in the ⌬covR mutant. These genes identified as differentially expressed by microarray analysis were consequently confirmed to exhibit altered transcript levels by realtime PCR assays. As shown in Fig. 10 , there was a strong positive correlation (R 2 ϭ 0.9) between the data obtained by these two different techniques.
DISCUSSION
Although it has been known for a number of pathogens, including GAS, GBS, and S. mutans, that CovS/CovR (or CovR) play a pivotal role in the regulation of virulence, the function of this system in S. suis has so far received little attention. In the present study, we carried out the first detailed functional investigation of CovR in the pathogenesis of S. suis 05ZYH33. Unlike most TCS members of histidine kinase response regulator pairs, CovR was identified as an orphan response regulator in 05ZYH33, similar to that of S. mutans (28) . This suggests that other phosphorelay systems might be involved in the phosphorylation of CovR or that, in the absence of CovS, an alternative sensor kinase or some low-molecularweight compounds, such as acetyl phosphate, might serve as phosphodonors (51, 81) .
To determine the role of CovR in S. suis, we constructed a ⌬covR mutant, and remarkable phenotypic changes were readily observed, such as increased hemolytic activity, longer chains, and thicker capsule walls. In light of the interactions between S. suis and host epithelial or endothelial cells, we tested the ability of the ⌬covR mutant to adhere to these cells and found that adherence of the ⌬covR mutant to both epithelial cells (Hep-2) and endothelial cells (HUVEC) was greatly increased. Charland et al. demonstrated that S. suis could adhere to brain microvascular endothelial cells and HUVEC, especially brain microvascular endothelial cells (10) . A previous study had shown that S. suis was able to adhere to different epithelial cells and that the levels of adherence were, in general, similar in human and animal-derived cells (41) . As a confirmation of this, we observed that levels of adherence of S. suis 05ZYH33 to the above-mentioned cells from piglets and humans were comparable in our preexperiments.
To induce diseases, S. suis must be able to survive in the bloodstream after its transmission via the respiratory tract. An early theory suggested that S. suis is taken up by MONOs, allowing the bacteria to survive and travel intracellularly in the circulation (80) . Neutrophils may play an important role in the pathogenesis of infection, given that infiltration by neutrophils and mononuclear cells is frequently observed in lesions caused by S. suis (8) . Our work shows that the ⌬covR mutant survived more than the wild type in human PMNs and MONOs. It is reasonable to explain this phenomenon by the thicker capsule of the ⌬covR strain, since it has been reported that the capsular polysaccharide (CPS) of S. suis protects against phagocytosis and against the bactericidal activity of leukocytes (6, 9, 48, 59, 62, 63, 79) . The work of Segura et al. demonstrated that S. suis serotype 2 is able to interact with MONOs of human origin, inducing the release of large amounts of the proinflammatory cytokines (61) .
In a piglet intravenous-challenge model, the ⌬covR mutant has been shown to exhibit significantly enhanced virulence compared to the wild-type strain, as judged from several aspects, including the survival times of infected piglets, colonization abilities, and pathological observations. To examine the pathological changes in piglets that died from the ⌬covR mutant, optical microscopy and TEM were used. Many organs, including alveolar epithelium, hepatic cell, kidney, and cardiac muscle, exhibited cristate disruption of the chondriosomes (Fig. 9 and data not shown) . Pathological changes were particularly manifested in kidney and cardiac muscle, although pathological observations were similar in the two groups. More strikingly, the ⌬covR mutant-infected group died 9 h after inoculation while the wild-type-infected group died at 2 days. The autopsy specimen from the ⌬covR mutant-infected group showed clearly visible disseminated intravascular coagulation in kidney tissue, abdomens, and backs of piglets (data not shown), whereas the wild-type-infected group did not. All of these results indicate that the ⌬covR mutant is more lethal than the wild-type strain, and the ⌬covR strain upregulated many virulence genes related to physical and pathological changes.
The role of CovR in the pathogenesis of S. suis was studied in an experimental infection model in piglets. Since we were unable to determine a 50% lethal dose for S. suis, it was decided to compare the virulence of the ⌬covR mutant with that of the wild-type strain in a competitive-infection assay in piglets. This kind of cocolonization experiment has been successfully applied to determine the virulence of mutants of Actinobacillus pleuropneumoniae and S. suis in piglets (14, 15, 21) . The data showed that the ⌬covR strain was capable of colonizing the most-examined organs, including heart, liver, kidney, and brain, with higher efficiency than the wild-type strain, which indicates that some components regulated by CovR may play roles in the colonization process. The reason for the mutant strain colonizing the lung less efficiently than the wild-type strain is not known but may be related to tissuespecific effects.
Considering the global regulatory role of CovR in both GAS and GBS, an expression-profiling analysis of S. suis 05ZYH33 and the ⌬covR mutant was carried out to determine which S. suis serotype 2 virulence genes belong to the CovR regulon. This analysis revealed that transcription of as many as 8.9% of all chromosomal genes (n ϭ 195) was affected by covR disruption. Of note, several proven or putative virulence-associated genes were included, such as cps2C (one open reading frame of the CPS biosynthesis operon, 05SSU0566), the sialic acid synthase-coding gene (05SSU0581), srtA (sortase A; 05SSU1074), sda (DNase streptodornase; 05SSU2011), lbp (laminin-binding protein; 05SSU0330), and hly (hemolysin; 05SSU1668).
The CPS of S. suis serotype 2 is composed of five kinds of sugars-the monosaccharides galactose, glucose, N-acetyl-Dglucosamine, rhamnose, and N-acetylneuraminic acid (sialic acid) (34)-and is so far the only proven critical virulence factor, based on the observation that unencapsulated isogenic mutants showed increased hydrophobicity and phagocytosis using murine and porcine phagocytes. More importantly, unencapsulated mutants were found to be completely avirulent and rapidly cleared from circulation in pig and mouse models of infection (9, 63) . As an important component of CPS, sialic acid has been proven to be related to virulence for other bacterial agents of meningitis (50, 78) . The CPS biosynthesis (cps) locus of S. suis serotype 2 consists of 14 open reading frames, among which cps2C could be involved not only in the chain length determination of the serotype 2 capsule, but also in export of the polysaccharide (63) . Consistent with the phenotypic changes of the ⌬covR mutant, with formation of longer chains and production of thicker capsules, transcripts of the cps2c gene were more abundant in the absence of CovR. Additionally, a gene (05SSU0581) encoding a putative sialic acid synthase that may be involved in capsule development was also overexpressed in the ⌬covR mutant. Since it has been generally accepted that there is a close correlation between encapsulation and resistance to phagocytosis or bactericidal effects, it is reasonable that the ⌬covR mutant exhibits enhanced capabilities for resistance to phagocytosis and killing by human PMNs and MONOs compared to S. suis 05ZYH33.
Bacterial adherence to host cell surfaces is the first step in colonization and the establishment of an effective infection. At this initial stage of infection, proteins on the surfaces of bacterial cells may function as adhesins for specific adherence (5, 20, 53, 57) . In this process, sortase A (SrtA, also referred to as sortase) plays a key role in the cleavage and anchoring of surface proteins with an LPXTG motif to the cell wall (4, 72).
In several important gram-positive pathogens, it has been demonstrated that a mutant deficient in the srtA gene caused defects in the cell wall sorting of such surface proteins, including some surface-associated adherence factors, and consequently led to a significant decrease in either adhesion or virulence (35, 40, 82) . Recently, Vanier et al. demonstrated that an S. suis mutant strain lacking the srtA gene had reduced capacity to adhere to porcine brain microvascular endothelial cells, as well as plasma fibronectin, cellular fibronectin, and collagen type I (76). However, they found that disruption of srtA had little effect on the virulence of S. suis in a mouse intraperitoneal model of infection. In contrast to this, our recent experiments with the ⌬srtA mutant clearly showed that SrtA is essential for S. suis serotype 2 virulence in a piglet model (77) . The reason for these conflicting results is unclear but may be related to experimental differences, such as the use of different bacterial strains and animal models. Using DNA microarray analysis and quantitative RT-PCR, we found that the transcription level of the srtA gene in the ⌬covR mutant was much higher than that in the wild-type strain. Moreover, transcription of the gene 05SSU0330 encoding laminin-binding protein (LBP), an important surface protein adhesin that has been proven to promote adhesion of GAS to Hep-2 cells and invasion of GBS into the bloodstream (65, 70) , was also repressed by CovR. As confirmation of these findings, the adherence and colonization abilities of the ⌬covR mutant were found to be significantly increased compared to those of the wild-type strain, 05ZYH33. Furthermore, in agreement with the increased hemolytic activity of the ⌬covR mutant and extensive hemorrhage in multiple organs at autopsy in piglets infected with the ⌬covR strain, the hly gene encoding hemolysin is upregulated in the absence of CovR.
Bacteria have selected mechanisms to express only the appropriate subset of genes conferring a growth or survival advantage in a given situation (12) . The expression of many bacterial genes is regulated at the initiation of transcription by regulators that, in response to specific environmental and/or cellular signals, bind at the promoters of target genes to activate or repress them (23) . The genome of S. suis 05ZYH33 contains approximately 51 genes that encode homologues of transcriptional regulators, including 15 two-component regulatory systems (11) . Many genes encoding proven or putative transcriptional regulators were differentially expressed in the ⌬covR mutant (Table 3; see Table S2 in the supplemental material). 05SSU0447 encodes a protein called fatty acyl-responsive regulator (P30 protein), which has been identified as a fatty acid and fatty acyl-coenzyme A-responsive DNA-binding protein, autoregulates its own expression, and may modulate citric acid cycle expression in response to long-chain fatty acids (55) . It belongs to transcriptional regulators of the GntR family, which are involved in virulence gene control in Brucella melitensis. Attenuated mutants of the GntR family were identified and confirmed to replicate at lower rates in mice and to be attenuated in cellular models (25, 44) . 05SSU0706 encodes a protein belonging to the DeoR family. Some regulators of the DeoR family are involved in sugar metabolism, but many proteins of this family have no experimentally defined function (52, 56 deoR1 mutant was shown to be strongly attenuated in human macrophages (37) , which is consistent with a possible role of deoR1 in virB activation in this cellular model. The upregulation of 05SSU0447 and 05SSU0706 indicates that both of them might be involved in virulence gene control in S. suis. The phosphoenolpyruvate-carbohydrate phosphotransferase system (PTS) was originally described as a sugar phosphorylation system (39) and plays a major role in sugar transport and in the regulation of essential physiological processes in many bacteria (16, 54, 58, 71) . In addition to their roles in sugar transport, PTS proteins participate in many other physiological processes, such as signal transduction, chemotaxis, regulation of carbon metabolism, and coordination of carbon and nitrogen metabolism (2, 16, 54) . Recent studies have also shown that PTS components are associated with bacterial virulence: signature-tagged mutagenesis screenings have identified PTS genes as virulence factors in some pathogenic streptococci and salmonellae (26, 32, 43, 73) . There are 27 genes encoding PTS components (11) in the genome of S. suis 05ZYH33, and expression levels of 05SSU0398, 05SSU0710, 05SSU1038, 05SSU1401, and 05SSU1780 are upregulated in the ⌬covR mutant. 05SSU0706, a gene upstream of 05SSU0710 that encodes a transcriptional regulator of sugar metabolism, is also upregulated. Thus, it seems plausible that these PTS proteins not only take part in metabolism, but are also involved in virulence gene control in S. suis.
Transcripts of 05SSU0625 and 05SSU0627, which encode histone acetyltransferase HPA2 and related acetyltransferases and carbamate kinase, respectively, together with the transcripts of 05SSU0631 and 05SSU01652, which encode arginine repressors belonging to the arginine deiminase system (ADS), are all upregulated in the mutant strain compared to the wild type. The ADS can be considered a system that protects oral streptococci and S. pyogenes against acidic stress (7, 13) . Thus, the ADS might facilitate S. suis survival within the different niches of the host and thereby probably contributes to S. suis pathogenesis (24) . 05SSU1636 encodes lactoylglutathione lyase (LGL), which is an enzyme that catalyzes the conversion of toxic methylglyoxal, derived from glycolysis, to S-D-lactoylglutathione (29, 33) . Methylglyoxal inhibits the growth of cells in all types of organisms. In S. mutans, LGL functions in the detoxification of methylglyoxal, resulting in increased aciduricity (38) . In this study, upregulation of 05SSU1636 might contribute to the enhanced virulence of the ⌬covR strain.
In conclusion, this investigation has provided initial insight into the global regulatory role of CovR in S. suis serotype 2, especially its negative control of S. suis serotype 2 virulence. However, further studies are necessary to define a specific CovR recognition and binding sequence and are currently being pursued in our laboratory. Determining the nature of the interaction between CovR and its target promoters is the first step toward understanding the CovR signaling pathway and identifying genes directly regulated by CovR.
